Sovereign Health Group Blog

Reach out to us today! Most Private Insurance Accepted
NFL legend Brett Favre reveals how it feels to live with addiction
05-28-18 Category: Addiction

Drug addiction has affected innumerable lives in the United States, be it celebrities or commoners. Recently, former American footballer Brett Lorenzo Favre confessed to having been admitted thrice to addiction treatment rehab to get rid of his dependence on alcohol and prescription drugs. Favre’s drinking problem and addiction to pain reliever Vicodin had landed him […]


FDA issues warning letters to three manufacturers of kratom products
05-28-18 Category: Addiction

In an effort to combat the opioid epidemic in the United States, the Food and Drug Administration (FDA) recently issued warning letters to three companies for marketing and distributing more than 65 kratom products with deceptive medical claims of treating opioid addiction and withdrawal. The agency has sought response from the three companies – Front […]


US life expectancy is likely to go down for third consecutive year
05-28-18 Category: Drug Addiction

The life expectancy of an average American is likely to go down for the third consecutive year in 2017, as the death rate in the country increased last year, according to the latest report released recently by the Centers for Disease Control and Prevention (CDC). The provisional estimates mentioned in the report are based on […]


ED doctors should opt for evidence-based opioid treatment, says Surgeon General
05-28-18 Category: Addiction

Emergency department (ED) physicians need to play a bigger role in propagating evidence-based opioid addiction treatments, including harm reduction, said U.S. Surgeon General Dr. Jerome Adams while speaking at the American College of Emergency Physicians forum in Washington, D.C. on May 25, 2018. Dr Jerome highlighted the effectiveness of harm reduction tactics, such as needle […]


FDA approves first non-opioid drug to manage opioid withdrawal symptoms
05-18-18 Category: Opioid

The U.S. Food and Drug Administration (FDA) on May 16, 2018 approved the use of first non-opioid drug to manage withdrawal symptoms in chronic opioid users. While the drug, Lucemyra (lofexidine hydrochloride), can help alleviate the misery accompanying opioid withdrawal, experts say the medication may not deal with symptoms completely. Lucemyra is an oral, selective […]


1 2 3 4
Close X